| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Synaptotagmin | 3.11e-06 | 20 | 97 | 4 | IPR001565 | |
| Pubmed | 3.34e-10 | 5 | 101 | 4 | 39116209 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 10531343 | ||
| Pubmed | Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting. | 9.49e-08 | 4 | 101 | 3 | 30545844 | |
| Pubmed | Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells. | 4.72e-07 | 6 | 101 | 3 | 12860971 | |
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 8626542 | ||
| Pubmed | Distinct developmental expression of synaptotagmin I and IX in the mouse brain. | 1.97e-06 | 9 | 101 | 3 | 16407767 | |
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 10734137 | ||
| Pubmed | Alternative splicing of synaptotagmins involving transmembrane exon skipping. | 8.35e-06 | 2 | 101 | 2 | 10556508 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15022265 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20002670 | ||
| Pubmed | Expression of NCAM isoforms during skeletal myogenesis in the mouse embryo. | 8.35e-06 | 2 | 101 | 2 | 1421527 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26990843 | ||
| Pubmed | STAT5BN642H drives transformation of NKT cells: a novel mouse model for CD56+ T-LGL leukemia. | 8.35e-06 | 2 | 101 | 2 | 30967617 | |
| Pubmed | L1-CAM and N-CAM: From Adhesion Proteins to Pharmacological Targets. | 8.35e-06 | 2 | 101 | 2 | 26478212 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22723769 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 1723996 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8509458 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8071656 | ||
| Pubmed | Homophilic NCAM interactions interfere with L1 stimulated neurite outgrowth. | 8.35e-06 | 2 | 101 | 2 | 10611478 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18972120 | ||
| Pubmed | Piezo1 in Smooth Muscle Cells Is Involved in Hypertension-Dependent Arterial Remodeling. | 8.35e-06 | 2 | 101 | 2 | 26526998 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 1894011 | ||
| Pubmed | 1.42e-05 | 493 | 101 | 9 | 15368895 | ||
| Pubmed | 2.11e-05 | 653 | 101 | 10 | 22586326 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12526776 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 10531344 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17050727 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19018795 | ||
| Pubmed | Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice. | 2.50e-05 | 3 | 101 | 2 | 18441096 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27436580 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 29521261 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 7613634 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 15707673 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 8921257 | ||
| Pubmed | NCAM1, TACR1 and NOS genes and temperament: a study on suicide attempters and controls. | 4.99e-05 | 4 | 101 | 2 | 21577011 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 7706555 | ||
| Pubmed | Synaptotagmin-mediated vesicle fusion regulates cell migration. | 4.99e-05 | 4 | 101 | 2 | 20473299 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 2132728 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 23071553 | ||
| Pubmed | A molecular mechanism for LINC complex branching by structurally diverse SUN-KASH 6:6 assemblies. | 8.30e-05 | 5 | 101 | 2 | 33393904 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 2570027 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 9331350 | ||
| Pubmed | Cross-reactivity of anti-programmed death ligand 2 polyclonal antibody in mouse tissues. | 8.30e-05 | 5 | 101 | 2 | 23090063 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 11807022 | ||
| Pubmed | Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. | 8.30e-05 | 5 | 101 | 2 | 19053060 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA PIEZO1 SIPA1L3 L1CAM FGFRL1 CHD8 RPSA TXNRD2 AHNAK SPEN HECTD1 ANKRD33B | 8.83e-05 | 1105 | 101 | 12 | 35748872 |
| Pubmed | SYNE1 PIEZO1 SIPA1L3 PHRF1 HLA-G CHD8 RPSA SYT7 SEMA4C SRRT CLPTM1L PTCD1 BOP1 SPEN | 1.09e-04 | 1497 | 101 | 14 | 31527615 | |
| Pubmed | 1.19e-04 | 650 | 101 | 9 | 38777146 | ||
| Pubmed | Expression of connexins in the developing olfactory system of the mouse. | 1.24e-04 | 6 | 101 | 2 | 1332989 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 9593903 | ||
| Pubmed | p59fyn and pp60c-src modulate axonal guidance in the developing mouse olfactory pathway. | 1.24e-04 | 6 | 101 | 2 | 9658338 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 7607687 | ||
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 1.24e-04 | 6 | 101 | 2 | 33058875 | |
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 1.74e-04 | 7 | 101 | 2 | 26816381 | |
| Pubmed | Pax3: a paired domain gene as a regulator in PNS myelination. | 1.74e-04 | 7 | 101 | 2 | 7546735 | |
| Pubmed | 1.74e-04 | 7 | 101 | 2 | 10964956 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA SYNE1 RPSA CHD3 ZNF512B SRRT GANAB AHNAK BOP1 SPEN PLOD1 | 1.94e-04 | 1024 | 101 | 11 | 24711643 |
| Pubmed | 2.31e-04 | 8 | 101 | 2 | 19914235 | ||
| Pubmed | Evolution of the mouse t haplotype: recent and worldwide introgression to Mus musculus. | 2.31e-04 | 8 | 101 | 2 | 1495973 | |
| Pubmed | 2.31e-04 | 8 | 101 | 2 | 7750641 | ||
| Pubmed | Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract. | 2.31e-04 | 8 | 101 | 2 | 16116452 | |
| Pubmed | Ca(2+)-dependent and -independent activities of neural and non-neural synaptotagmins. | 2.31e-04 | 8 | 101 | 2 | 7791877 | |
| Pubmed | 2.38e-04 | 103 | 101 | 4 | 10819331 | ||
| Pubmed | 2.38e-04 | 103 | 101 | 4 | 32744500 | ||
| Pubmed | FLNA SYT3 SYNE1 SIPA1L3 L1CAM NCAM1 RPSA CHD3 PITPNM1 SRRT NGEF SCAPER MTMR2 | 2.59e-04 | 1431 | 101 | 13 | 37142655 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.95e-04 | 109 | 101 | 4 | 33554859 | |
| Pubmed | 2.97e-04 | 9 | 101 | 2 | 8416841 | ||
| Pubmed | Fezf1 and Fezf2 are required for olfactory development and sensory neuron identity. | 2.97e-04 | 9 | 101 | 2 | 21452247 | |
| Pubmed | An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. | 2.97e-04 | 9 | 101 | 2 | 22084437 | |
| Pubmed | Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases. | 2.97e-04 | 9 | 101 | 2 | 17088432 | |
| Pubmed | 2.97e-04 | 9 | 101 | 2 | 8901523 | ||
| Pubmed | 2.97e-04 | 9 | 101 | 2 | 18292501 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.06e-04 | 440 | 101 | 7 | 34244565 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.17e-04 | 202 | 101 | 5 | 33005030 | |
| Pubmed | 3.30e-04 | 46 | 101 | 3 | 33403043 | ||
| Pubmed | 3.51e-04 | 47 | 101 | 3 | 24357327 | ||
| Pubmed | 3.70e-04 | 10 | 101 | 2 | 29127326 | ||
| Pubmed | SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase. | 3.70e-04 | 10 | 101 | 2 | 19720090 | |
| Pubmed | 3.70e-04 | 10 | 101 | 2 | 22124325 | ||
| Pubmed | Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. | 3.70e-04 | 10 | 101 | 2 | 9914469 | |
| Pubmed | 3.70e-04 | 10 | 101 | 2 | 9184108 | ||
| Pubmed | 3.70e-04 | 10 | 101 | 2 | 33074477 | ||
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 4.22e-04 | 50 | 101 | 3 | 29560723 | |
| Pubmed | 4.51e-04 | 11 | 101 | 2 | 21273415 | ||
| Pubmed | 4.51e-04 | 11 | 101 | 2 | 1421760 | ||
| Pubmed | Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. | 4.51e-04 | 11 | 101 | 2 | 10521398 | |
| Pubmed | 4.51e-04 | 11 | 101 | 2 | 22826121 | ||
| Pubmed | 4.51e-04 | 11 | 101 | 2 | 19053061 | ||
| Pubmed | 4.74e-04 | 52 | 101 | 3 | 34039624 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.84e-04 | 475 | 101 | 7 | 31040226 | |
| Pubmed | 5.41e-04 | 12 | 101 | 2 | 21344388 | ||
| Pubmed | 5.41e-04 | 12 | 101 | 2 | 25007825 | ||
| Pubmed | 5.41e-04 | 12 | 101 | 2 | 16225856 | ||
| Pubmed | Multiple influences on the migration of precerebellar neurons in the caudal medulla. | 5.41e-04 | 12 | 101 | 2 | 11807023 | |
| Pubmed | 5.41e-04 | 12 | 101 | 2 | 9396756 | ||
| Pubmed | 6.19e-04 | 234 | 101 | 5 | 36243803 | ||
| Pubmed | PCR-analyzed microsatellites: data concerning laboratory and wild-derived mouse inbred strains. | 6.38e-04 | 13 | 101 | 2 | 1794054 | |
| Pubmed | 6.38e-04 | 13 | 101 | 2 | 7906967 | ||
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 6.38e-04 | 13 | 101 | 2 | 24559674 | |
| Pubmed | 6.38e-04 | 13 | 101 | 2 | 11543631 | ||
| Interaction | SYT10 interactions | 2.28e-06 | 6 | 99 | 3 | int:SYT10 | |
| GeneFamily | Synaptotagmins | 3.08e-07 | 17 | 63 | 4 | 765 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 154 | 101 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 154 | 101 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-06 | 164 | 101 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 3.84e-06 | 183 | 101 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | Ciliated-cil-3|World / Class top | 5.06e-06 | 192 | 101 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.69e-06 | 196 | 101 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.86e-06 | 197 | 101 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 197 | 101 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.86e-06 | 197 | 101 | 6 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 199 | 101 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.21e-06 | 199 | 101 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 151 | 101 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 151 | 101 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 155 | 101 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 155 | 101 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-05 | 159 | 101 | 5 | 57df5c9b678a15eb5e025e1a80de2e6769cc13d5 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.31e-05 | 161 | 101 | 5 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.31e-05 | 161 | 101 | 5 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | PBMC-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 3.49e-05 | 81 | 101 | 4 | 6d1e524f000b71c935359afc801a1d31f218fec8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-05 | 167 | 101 | 5 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 169 | 101 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | NS-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.29e-05 | 170 | 101 | 5 | f6a0162bb690dbc19ff1cec64cb933744ad3b496 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.29e-05 | 170 | 101 | 5 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.41e-05 | 86 | 101 | 4 | 2df674969383d93509ea9e201452cfda702fae40 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.41e-05 | 86 | 101 | 4 | 8ead39a100fa5aedf93a2206edd9828538f990a5 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 173 | 101 | 5 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.20e-05 | 177 | 101 | 5 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 5.34e-05 | 178 | 101 | 5 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-05 | 179 | 101 | 5 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.93e-05 | 182 | 101 | 5 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 6.41e-05 | 185 | 101 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 6.57e-05 | 186 | 101 | 5 | 58ab1360a1730655a5939295ba05997ac4a2d14e | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.74e-05 | 187 | 101 | 5 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.91e-05 | 188 | 101 | 5 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 189 | 101 | 5 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 189 | 101 | 5 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 189 | 101 | 5 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.45e-05 | 191 | 101 | 5 | 04faa7d2237e45418611153294eb6f7bb690cbde | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | a6c9df4cb4d09e0a91b3c8d7f3e091a7e95e6471 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.82e-05 | 193 | 101 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.02e-05 | 194 | 101 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 194 | 101 | 5 | 52e09b14159b609af00264a8f38accf37ba8f464 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.21e-05 | 195 | 101 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 8.21e-05 | 195 | 101 | 5 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.21e-05 | 195 | 101 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.21e-05 | 195 | 101 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 8.21e-05 | 195 | 101 | 5 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.21e-05 | 195 | 101 | 5 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 8.21e-05 | 195 | 101 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.41e-05 | 196 | 101 | 5 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 196 | 101 | 5 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.41e-05 | 196 | 101 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.41e-05 | 196 | 101 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.41e-05 | 196 | 101 | 5 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.41e-05 | 196 | 101 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.41e-05 | 196 | 101 | 5 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 8.62e-05 | 197 | 101 | 5 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-05 | 197 | 101 | 5 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.62e-05 | 197 | 101 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 197 | 101 | 5 | dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.62e-05 | 197 | 101 | 5 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.62e-05 | 197 | 101 | 5 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tem/emra_CD8|Liver / Manually curated celltypes from each tissue | 8.83e-05 | 198 | 101 | 5 | 2fc2a4638c458ae793ac090a29d27b75fc9e6af6 | |
| ToppCell | proximal-Epithelial-Neuroendocrine|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.83e-05 | 198 | 101 | 5 | 5dea6078488d584513c0bdbf5bba54877310b54a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 198 | 101 | 5 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.83e-05 | 198 | 101 | 5 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.83e-05 | 198 | 101 | 5 | faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0 | |
| ToppCell | proximal-Epithelial-Neuroendocrine-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.83e-05 | 198 | 101 | 5 | 00ccf3020667cf2130bc354b441b65c0b1b0e862 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.83e-05 | 198 | 101 | 5 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | proximal-3-Epithelial-Neuroendocrine|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.83e-05 | 198 | 101 | 5 | a6bc043faf68468d46bac441cf7447c236c7bae4 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.83e-05 | 198 | 101 | 5 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 9.04e-05 | 199 | 101 | 5 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.04e-05 | 199 | 101 | 5 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 9.04e-05 | 199 | 101 | 5 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 6e7f7214317f2af2ba8523df9896f54b7294d58a | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 5f499595597c10857bba8272f62afe4d32d733ac | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 9.25e-05 | 200 | 101 | 5 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.25e-05 | 200 | 101 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.66e-04 | 121 | 101 | 4 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.19e-04 | 130 | 101 | 4 | ab141d91988a5de6d092757377a53f7de3707556 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.19e-04 | 130 | 101 | 4 | 3d81151ee1369d819843826fc6ac197d83255e1d | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 132 | 101 | 4 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 132 | 101 | 4 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 2.57e-06 | 197 | 100 | 8 | 4556_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.57e-06 | 197 | 100 | 8 | 7231_DN | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.32e-04 | 80 | 95 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | hemoglobin measurement, mean corpuscular hemoglobin concentration | 2.84e-04 | 8 | 95 | 2 | EFO_0004509, EFO_0004528 | |
| Disease | Macrocephaly | 5.54e-04 | 11 | 95 | 2 | C0221355 | |
| Disease | bilirubin measurement | 5.74e-04 | 442 | 95 | 7 | EFO_0004570 | |
| Disease | forced expiratory volume, response to bronchodilator | 5.98e-04 | 445 | 95 | 7 | EFO_0004314, GO_0097366 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 9.10e-04 | 14 | 95 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | diverticular disease | 1.01e-03 | 236 | 95 | 5 | EFO_0009959 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.20e-03 | 16 | 95 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 2.07e-03 | 21 | 95 | 2 | OBA_2045076 | |
| Disease | Malignant neoplasm of breast | 2.41e-03 | 1074 | 95 | 10 | C0006142 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 3.17e-03 | 26 | 95 | 2 | OBA_2045087 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HAIKMGWIQPRRPRD | 261 | Q14137 | |
| PWAMRRNQHMPLESR | 261 | Q6P093 | |
| APRRAELEMWLQGHP | 2331 | Q9HCK8 | |
| HPERVRQGKVWKAPS | 746 | Q99728 | |
| LERLPDPQRTHVMWA | 306 | Q96QU6 | |
| MEPGLEHALRRTPSW | 1 | Q9UGI9 | |
| HVPWRDMEGKTIPSS | 391 | Q9UIR0 | |
| GKLWATNHVPEMVRP | 86 | P51857 | |
| RTWAMAKGLVQHPPR | 686 | P33076 | |
| MVVPEDQLTRWHPRF | 321 | Q9H211 | |
| MIPRSTWKGPERLAH | 691 | O94983 | |
| VDVRGPDWHLKMPKI | 3921 | Q09666 | |
| PAIGTQKMELHVRWR | 746 | Q4L235 | |
| RVEKPRNHWMLVTGN | 256 | Q6P656 | |
| VHARDPRRGMSPQEW | 216 | A6NCL7 | |
| MEGKLVVWDIHRPPS | 466 | Q8TBY9 | |
| REMPGGPVWRKHYIT | 101 | P39900 | |
| RKSRGHELLWPAAPM | 1306 | Q6DT37 | |
| AHPEEGRKEPSMWLT | 431 | Q8N6L0 | |
| RSPSTHVMPNWVRKV | 321 | P02708 | |
| RWMLAGRPHPTLKGT | 2046 | O00763 | |
| EPAHVKENWIDPLMR | 141 | D6REC4 | |
| QHEGLPEPLMLRWKQ | 286 | P17693 | |
| IERIIMPGVVHWQSP | 61 | P19113 | |
| HTPQKRLMTPWEESN | 341 | Q9NP74 | |
| RHGVPDEMRKVESNW | 366 | Q6ZRQ5 | |
| PNRLHQVWLEPEGMD | 326 | Q9Y2Z2 | |
| TRQKGTWGPEERKMH | 76 | Q6DKI2 | |
| TLIHMQTGTPPWVKR | 316 | P41279 | |
| GHPRPDITWMKDDQA | 176 | Q8N441 | |
| NHVWLQPRVMRPTKP | 261 | Q9H0B8 | |
| VQKGWMPRESVLPHL | 1921 | Q92817 | |
| KDDGQHMWRPKRFPR | 201 | P23743 | |
| GENQLPVWMPTRHLK | 841 | P63132 | |
| HRPQKPREGAWDMED | 1426 | Q9P1Y6 | |
| WKRGQDRAVVDHMEP | 336 | Q6B0I6 | |
| IRWNPRMKPQEPIHN | 581 | Q13614 | |
| HEIRLMAEGAPKWPK | 126 | P32004 | |
| HRVVPDRWKGMTQEQ | 271 | Q9H4K1 | |
| SWDPLHVQGLRPRMS | 401 | Q9NZB8 | |
| APRKGWTLMHPGRLT | 691 | Q02809 | |
| VKPPWMALRVEQRKH | 101 | Q9NQV7 | |
| AQPPIELLRQWMDHG | 2306 | Q9P2D7 | |
| EWMVKCVVRNVHRPP | 181 | Q13795 | |
| DPPKDEKQGWRHVRI | 1201 | Q9ULT8 | |
| HVDLNPPSVREMLWG | 416 | Q5JSL3 | |
| MPAWGLEQRPHVAGK | 31 | Q96C57 | |
| VPRKPVKHTAMVSWG | 736 | P21333 | |
| WRHRELIMGEDPAQP | 681 | Q12873 | |
| AHRMKRPWQGQVEPQ | 46 | P07902 | |
| WIELAPLSMPRINHG | 306 | Q9H2C0 | |
| LIHAMPGKPWRTEQT | 91 | Q9BRF8 | |
| DTHLRILGKPVMERW | 31 | Q14353 | |
| DRPQPGWRESLKMRV | 51 | Q8N0W7 | |
| WEVKKMSPGRHVIPS | 171 | Q9BY12 | |
| AVRMTPGQALRHPWL | 521 | Q92630 | |
| KRWTGQVEMPKPSHL | 26 | P28476 | |
| QGEERPRLWVMPNHQ | 121 | Q96NZ9 | |
| DRVPMGKVPHLWGQS | 391 | P46019 | |
| VKRRWHEMAGPQLPE | 246 | Q8N344 | |
| RASPEPRWHLMGLVS | 676 | Q6UXH9 | |
| WLEEQHIPPMLRATG | 56 | Q0VD86 | |
| VTARRNPLHNPWGME | 216 | Q0VD86 | |
| RGTISREHPWEVMPD | 186 | P08865 | |
| GREHWAEMLANPRKP | 546 | Q9BQG1 | |
| HWADMLANPRRPIAQ | 356 | O00445 | |
| RDHWNEMLAYPRKPI | 476 | Q5T7P8 | |
| VKHWKDMIARPRQPV | 381 | O43581 | |
| VAWPRKIAPHGQNMT | 351 | P49683 | |
| RSTGQPWQPDKMLHL | 4741 | Q8NF91 | |
| HIKLGPSEVWRTERM | 1126 | O15061 | |
| TPPHWKEEMQRLRAY | 361 | P30414 | |
| ETRDMPWKPGPHRVF | 31 | P08709 | |
| WKRMIEARGIQPTQH | 706 | A6NCM1 | |
| YQAHREGIPVMRPLW | 716 | Q14697 | |
| SRVVCMIEWPEHPNK | 176 | P25103 | |
| ALRMIHPIPADSWRN | 156 | Q8N5V2 | |
| PLMEDAPQRLRWQAH | 66 | Q96HU1 | |
| RESMRKGHSLPWGKP | 636 | Q6AI14 | |
| QESTMERQKPEPLWH | 1211 | O60292 | |
| VRNKHPTGWKRTEEP | 1451 | O60292 | |
| ELLGRPMDSQWIPHA | 771 | P51692 | |
| KHPLMEEQVGPRWSR | 396 | Q9C0C4 | |
| HELSPPQKRMRRDWD | 71 | Q9BXP5 | |
| PVSHWRPRLALNVMA | 166 | Q96KA5 | |
| YRQQETEHIPRKMPW | 556 | Q8TCG1 | |
| WKPEIRLPSGSDHVM | 656 | P13591 | |
| HPDSPAKGAQWMRQI | 151 | O75333 | |
| WHGDIKKIMPDDPER | 346 | Q86WT6 | |
| TGRPDMQKHRVVAWL | 1066 | O00562 | |
| NAKMEEGIDRHVWPP | 306 | Q9UJT1 | |
| MLPKEIQAWLQEHRP | 101 | Q7Z7L9 | |
| IHKMPTLRRQVEWEP | 2596 | Q8N2C7 | |
| MVRETRHLWVGNLPE | 1 | Q96T58 | |
| HGPEEWKLMFRIQQR | 96 | Q5VVC0 | |
| HEAPGRWKPVAPRTM | 66 | D3DTV9 | |
| LEQEKEPWEPMRRHE | 56 | P17038 | |
| EKHRIWNHMDRPLPA | 156 | Q96KM6 | |
| WNVKRHEMVAEPPVV | 31 | Q9P255 | |
| EVAQPVPHDWRKMAE | 116 | Q9NNW7 | |
| EPWTRKRHRMVAEPP | 61 | Q96N22 | |
| MEHVSLPGTRLPRWA | 711 | Q92508 | |
| QMEPEPKLWRGRRNT | 121 | O75127 | |
| WHAKPMPRERADAII | 231 | P51854 | |
| SRRVWSPPRVHKVEM | 611 | O15209 | |
| MTELWHKSRPGSVVP | 236 | Q8TEY7 |